Additionally, we discovered that ARID1A mutation was correlated with OS (p = 0.0204) and DFS (p = 1.24e-5) in the RECA-EU cohort, but not in the TCGA-KIRC cohort or the 22 Korean ccRCC patients. Here, ARID1A is linked to nonpapillary renal cell carcinoma.